Olmesartan Medoxomil 20mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with or without food, as directed. It's essential to continue taking this medication as prescribed by your doctor or healthcare provider, even if you're feeling well. Establish a routine by taking your medication at the same time every day.
To stay hydrated, drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake. If you have difficulty swallowing pills, you can discuss the option of creating a liquid suspension with your doctor or pharmacist. If a liquid suspension is prepared, be sure to shake it well before use and measure the dose carefully using the provided measuring device or one obtained from your pharmacist.
Storing and Disposing of Your Medication
Store your medication at room temperature in a dry place, avoiding storage in a bathroom. If a liquid suspension is made from the tablets, refrigerate it and do not freeze. Discard any unused portion after 28 days. Keep all medications in a safe location, out of the reach of children and pets.
Missing a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take medication exactly as prescribed, usually once daily, with or without food.
- Do not stop taking the medication without consulting your doctor, even if you feel well.
- Maintain a healthy lifestyle: eat a balanced diet low in sodium, engage in regular physical activity, limit alcohol intake, and quit smoking.
- Monitor blood pressure regularly at home as advised by your doctor.
- Avoid potassium supplements or salt substitutes containing potassium unless specifically instructed by your doctor.
- Inform your doctor or dentist that you are taking olmesartan before any surgery or dental procedures.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden significant weight gain
Signs of high potassium levels, such as:
+ Abnormal heartbeat
+ Confusion
+ Weakness, lightheadedness, or dizziness
+ Feeling like passing out
+ Numbness or tingling
+ Shortness of breath
Severe dizziness or fainting
Persistent diarrhea
Severe diarrhea
Significant weight loss
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. If you are bothered by any of the following side effects or if they do not go away, contact your doctor:
Dizziness
This is not an exhaustive list of all possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe dizziness or fainting (especially when standing up)
- Unusual tiredness or weakness
- Swelling of the face, lips, tongue, or throat (signs of angioedema)
- Difficulty breathing or swallowing
- Signs of high potassium (e.g., muscle weakness, slow or irregular heartbeat)
- Signs of kidney problems (e.g., decreased urination, swelling in feet or ankles)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you are taking a medication that contains aliskiren and have either diabetes or kidney problems.
If you are breastfeeding or plan to breastfeed.
For Parents or Guardians:
If your child is under 1 year of age, do not administer this medication. It is not suitable for children younger than 1 year.
Additional Considerations:
This list is not exhaustive, and it is crucial to discuss all your medications (including prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. This will help ensure it is safe to take this medication in conjunction with your other treatments and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
When starting this medication, be cautious when driving or performing tasks that require alertness, as it may affect your ability to do so. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position, and be careful when climbing stairs.
Regularly check your blood pressure as directed by your healthcare provider. Additionally, have your blood work checked as instructed by your doctor, and discuss the results with them.
If you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult your doctor. Similarly, if you are on a low-salt or salt-free diet, discuss this with your doctor to ensure safe use of this medication.
When taking colesevelam, administer it at least 4 hours after taking this medication. Before using any over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, or certain natural products or aids, consult your doctor.
It is also important to discuss alcohol consumption with your doctor before drinking. In hot weather or during physical activity, be cautious and drink plenty of fluids to prevent dehydration.
If you experience excessive sweating, fluid loss, vomiting, or diarrhea, inform your doctor, as these conditions may lead to low blood pressure.
Note that this medication may be less effective in lowering blood pressure in Black patients. In some cases, your doctor may need to prescribe an additional medication to achieve the desired effect. If you have any questions or concerns, discuss them with your doctor.
Overdose Information
Overdose Symptoms:
- Profound hypotension (low blood pressure)
- Tachycardia (rapid heart rate)
- Bradycardia (slow heart rate)
- Dizziness
- Fainting
What to Do:
In case of overdose, seek immediate medical attention or call a poison control center. The national poison control center number is 1-800-222-1222. Treatment is supportive and symptomatic. If ingestion is recent, gastric lavage may be considered. Administer intravenous fluids to support blood pressure. Olmesartan is not dialyzable.
Drug Interactions
Contraindicated Interactions
- Aliskiren (in patients with diabetes or renal impairment)
Major Interactions
- Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride)
- Potassium supplements
- Salt substitutes containing potassium
- Lithium (increased serum lithium concentrations and toxicity)
- NSAIDs (including selective COX-2 inhibitors - may attenuate antihypertensive effect and increase risk of renal impairment)
Moderate Interactions
- Other antihypertensive agents (additive hypotensive effect)
- Diuretics (increased risk of hypotension)
- Colesevelam (decreased systemic exposure of olmesartan, administer olmesartan 4 hours before colesevelam)
Monitoring
Baseline Monitoring
Rationale: To establish baseline and guide initial dosing.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline renal function, as ARBs can affect renal hemodynamics.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline potassium levels, as ARBs can cause hyperkalemia.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Regularly, especially after dose adjustments, then periodically (e.g., monthly until stable, then every 3-6 months).
Target: <130/80 mmHg (or individualized target based on guidelines and patient comorbidities)
Action Threshold: If BP remains uncontrolled, consider dose increase or add-on therapy. If symptomatic hypotension occurs, reduce dose or discontinue.
Frequency: Periodically, especially in patients with pre-existing renal impairment, heart failure, or those on concomitant diuretics or NSAIDs (e.g., 1-2 weeks after initiation/dose change, then every 3-6 months).
Target: Within normal limits or stable from baseline.
Action Threshold: Significant increase (e.g., >30% from baseline or above upper limit of normal) may warrant dose reduction or discontinuation.
Frequency: Periodically, especially in patients with renal impairment, diabetes, or those on concomitant potassium-sparing diuretics or supplements (e.g., 1-2 weeks after initiation/dose change, then every 3-6 months).
Target: 3.5-5.0 mEq/L
Action Threshold: If >5.5 mEq/L, consider dose reduction, discontinuation, or management of hyperkalemia.
Symptom Monitoring
- Dizziness or lightheadedness (especially upon standing, indicative of hypotension)
- Fatigue or weakness
- Signs of hyperkalemia (e.g., muscle weakness, irregular heartbeat, tingling sensations)
- Signs of angioedema (e.g., swelling of face, lips, tongue, throat, difficulty breathing or swallowing)
- Signs of renal dysfunction (e.g., decreased urine output, swelling in ankles/feet)
Special Patient Groups
Pregnancy
Olmesartan is contraindicated in the second and third trimesters of pregnancy due to the risk of fetal injury and death. It should be discontinued as soon as pregnancy is detected. Exposure during the first trimester is generally considered less risky but still warrants discontinuation.
Trimester-Specific Risks:
Lactation
Limited data suggest that olmesartan is excreted into breast milk in rats. It is unknown if it is excreted in human milk. Due to the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Approved for hypertension in children 6 to <17 years of age. Dosing is weight-based for children <35 kg. Safety and effectiveness have not been established in pediatric patients younger than 6 years.
Geriatric Use
No overall difference in efficacy or safety has been observed between elderly and younger patients. However, greater sensitivity of some older individuals cannot be ruled out. No dosage adjustment is generally needed based solely on age, but careful monitoring of renal function and electrolytes is prudent, especially in those with age-related decline in renal function.
Clinical Information
Clinical Pearls
- Olmesartan medoxomil is a prodrug; the active form is olmesartan.
- Unlike ACE inhibitors, ARBs like olmesartan do not typically cause a cough, making them a good alternative for patients who develop cough with ACE inhibitors.
- Monitor for hyperkalemia, especially in patients with renal impairment, diabetes, or those taking potassium-sparing diuretics or supplements.
- Advise patients to avoid salt substitutes containing potassium.
- The full antihypertensive effect may take 2-4 weeks to develop.
- Contraindicated in pregnancy due to significant fetal harm, especially in the 2nd and 3rd trimesters.
Alternative Therapies
- Other Angiotensin II Receptor Blockers (ARBs): Valsartan, Losartan, Irbesartan, Candesartan, Telmisartan, Azilsartan
- Angiotensin-Converting Enzyme (ACE) Inhibitors: Lisinopril, Enalapril, Ramipril, Captopril
- Calcium Channel Blockers (CCBs): Amlodipine, Nifedipine, Diltiazem, Verapamil
- Thiazide Diuretics: Hydrochlorothiazide, Chlorthalidone
- Beta-blockers: Metoprolol, Atenolol, Carvedilol
- Other antihypertensive classes depending on patient comorbidities and guidelines.